BioSpace News Archive

Bristol Myers Squibb announced that its Board of Directors has declared a quarterly dividend of fifty-seven cents per share on the $.10 par value common stock of the company.

Kezar Life Sciences, Inc. announced that the Compensation Committee of the company’s Board of Directors granted three employees nonqualified stock options to purchase 33,000 shares of its common stock with an exercise price of $5.43 per share, which is equal to the closing price of Kezar’s common stock on March 2, 2023, the grant date of the awards.